Biogenic Synthesis of Silver Nanoparticles using


Journal

Pharmaceutical nanotechnology
ISSN: 2211-7393
Titre abrégé: Pharm Nanotechnol
Pays: United Arab Emirates
ID NLM: 101623431

Informations de publication

Date de publication:
2023
Historique:
received: 24 05 2022
revised: 15 10 2022
accepted: 21 10 2022
medline: 22 5 2023
pubmed: 13 12 2022
entrez: 12 12 2022
Statut: ppublish

Résumé

The emergence of novel nanobiomedicine has transformed the management of various infectious as well as non-infectious diseases. The present study was aimed to demonstrate the biosynthesis of silver nanoparticles using The biosynthesized LE-AgNPs were characterized by UV-Visible spectroscopy, Scanning electron microscopy (SEM), Transmission electron microscopy (TEM), X-ray diffraction, and Fourier transform infrared spectroscopy (FTIR) analysis. The antibacterial activity was checked by minimum inhibitory concentration (MIC) and zone of inhibition assays against Gram-positive and Gram-negative bacteria. The anticancer potential of biogenic LE-AgNPs was checked by cytotoxicity and genotoxicity assay against human cervical adenocarcinoma (HeLa) and human breast adenocarcinoma (MCF-7) cells. UV-visible spectroscopy confirmed the formation of silver nanoparticles by measuring the surface plasmon resonance peak of the colloidal solution at 410-440 nm. The results of SEM and TEM revealed the distribution and spherical shape of 20-50 nm sized AgNPs. XRD spectrum confirmed the characteristic peaks at the lattice planes 110, 111, 200, 220 and 311 of silver which confirmed the crystalline nature of biosynthesized LE-AgNPs. FTIR spectrum of plant extract and biogenic LE-AgNPs was recorded in between 1635-3320 cm The overall findings from the present investigation indicated that the AgNPs synthesized using

Identifiants

pubmed: 36503464
pii: PNT-EPUB-128113
doi: 10.2174/2211738511666221207153116
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antioxidants 0
Silver 3M4G523W1G
Anti-Infective Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

180-193

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Kailas D Datkhile (KD)

Department of Molecular Biology and Genetics, Krishna Institute of Medical Sciences (Deemed to be University), Taluka-Karad, Dist-Satara, Pin-415 539, Maharashtra, India.

Pratik P Durgawale (PP)

Department of Molecular Biology and Genetics, Krishna Institute of Medical Sciences (Deemed to be University), Taluka-Karad, Dist-Satara, Pin-415 539, Maharashtra, India.

Satish R Patil (SR)

Department of Molecular Biology and Genetics, Krishna Institute of Medical Sciences (Deemed to be University), Taluka-Karad, Dist-Satara, Pin-415 539, Maharashtra, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH